Federal Advocacy / Issues / Legislation

Join in the effort to promote the Federal Patient Access to Pharmacist's Services.  Take action



Community pharmacy advocacy
and issues at the national level with NCPA.  Read more 



Health-system pharmacy advocacy
and issues at the federal level with  Find out more.


Click here for contact information to Montana's Congressional Delegation
Email, phone, fax and mailing address for US Representative Ryan Zinke, Senator Steve Daines and Senator Jon Tester.


NCPA’s Advocacy Report provides a weekly detailed summary of recent and breaking legislative, regulatory and state developments impacting independent community pharmacy, and NCPA efforts to effect policies to benefit its membership and the industry. The weekly report is distributed to NCPA leadership, key committees, allied organizations / stakeholders and major contributors to the NCPA LDF and PAC. 

Week Ending June 10, 2017
NCPA Urges Key Medicaid Managed Care Rules Be Retained: In light of the fact that the Administration is currently reviewing the policies included in the final Medicaid managed care rule released last year (88 Fed. Reg. 27498, May 6, 2016), NCPA wrote the new Administrator of CMS, Seema Verma, to offer suggestions for provisions that are critical for retention and also offer one suggestion for expansion or addition. Read the full report.

Week Ending June 3, 2017
NCPA Submits Comments on CMS' Proposed Guidance on DIR Reporting:
This week submitted comments to CMS regarding their proposed guidance on how Part D plan sponsors report direct and indirect remuneration (DIR). While the proposed CMS guidance will not change existing policy with regard to DIR fees, it does have the potential to require plans to provide greater granularity to CMS on DIR amounts and the types of arrangements they put into place. CMS has responded positively...Read the full report.

Week Ending May 20, 2017
CMS Releases Annual Part D Plan Sponsor DIR Reporting Guidance Including Details on Reporting Pharmacy DIR: This week CMS released a memo proposing guidance for Part D sponsors on reporting DIR data for CY 2016. Part D sponsors are required to report DIR data at the plan benefit package level (“summary level”) on the Summary DIR Report. CMS is modifying how pharmacy DIR is collected in the Summary DIR Report.  Read the full report.

Week Ending May 13, 2017
NCPA CEO Discusses Prescription Drugs with HHS Secretary Price: This week NCPA CEO Doug Hoey represented the organization in a meeting with the Health and Human Services (HHS) Secretary, Dr. Tom Price. Earlier this year NCPA requested a meeting with the Secretary to talk about the role of PBMs in rising prescription drug spending and how community pharmacists can help lower those costs and improve health outcomes.  Read the full report.
Documents referenced in this report:  Letter to Senator McConnell and Pharmacy Fact Sheet.

Week Ending May 6, 2017
Medicare Pharmacy Choice and Access Bill Introduced in the Senate: The Ensuring Seniors Access to Local Pharmacies Act, S. 1044, was introduced by Senators Shelley Moore Capito (R-WV), Sherrod Brown (D-OH), Tom Cotton (R-AK) and Joe Manchin (D-WV). The bill would allow community pharmacies in medically underserved areas to participate in preferred pharmacy networks if they can meet the terms and conditions the networks require. Read the full report.

Week Ending April 29, 2017
NCPA Congressional Pharmacy Fly-In Wrap Up
: NCPA held its 49th annual meeting with over 200 independent community pharmacists visiting Capitol Hill in Washington, D.C. this week to share with Congress real solutions to the problem of skyrocketing prescription drugs.  Read the full report.
 

Week Ending April 22, 2017
You Can Still Join the Fight Against PBMs. Come to D.C for the Congressional Fly-In April 26 & 27:  Emails, phone calls, and faxes to your elected officials in Washington can get their attention, but face-to-face meetings carry the greatest weight. We need YOU to share your story about PBM abuses against your patients and your business on Capitol Hill next week during the NCPA Congressional Pharmacy Fly-In April 26-27. 

Week Ending April 15, 2017
Specialty Rxs Require a Special Dispensing Fee Pharmacy Groups Tell CMS:  Concerned that states may not fully cover the cost of acquiring and dispensing Medicaid specialty drugs, NCPA, NACDS and the  National Association of Specialty Pharmacy  (NASP) wrote to CMS this week, seeking a meeting.  Read the complete weekly report.

Week Ending April 8, 2017
Medicare Pharmacy Choice and Access House Bill Introduced This Week:
The Ensuring Seniors Access to Local Pharmacies Act, H.R. 1939, was introduced by Reps. Morgan Griffith (R-VA) and Peter Welch (D-VT) on April 5th. The bill would allow community pharmacies in medically underserved areas to participate in Medicare Part D preferred pharmacy networks if they can meet the terms and conditions the networks require. Read the complete weekly report --- and note Montana's mention at the end of the report.

Week Ending April 1, 2017
118 Health Care Groups Support Bills Banning Retroactive Pharmacy DIR Fees:  In a strong display of unity, 118 health care organizations have signed on to letters supporting companion bills in the Senate and House of Representatives – S. 413/H.R. 1038, the Improving Transparency and Accuracy in Medicare Part D Drug Spending Act – that would prohibit retroactive pharmacy direct and indirect remuneration (DIR) fees in the Medicare Part D program.  Read the complete weekly report.